Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in F36VMpl-based in vivo selection among large animal models.

Robert E Richard1, R Angelo De Claro, James Yan

  • 1Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|September 29, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Models of care for the management of alcohol use disorder in general hospital settings and transition to the community: a scoping review.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Same author

Characterization of hematopoietic stem cell-derived microglia-like cells in nonhuman primates.

Blood advances·2026
Same author

Characteristics and Risk Factors of Atypical Periprosthetic Femoral Fractures Following Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.

Arthroplasty today·2026
Same author

[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy.

Blood·2026
Same author

<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention.

Molecular therapy. Advances·2026
Same author

Selpercatinib and the Crossover Conundrum: Potential Impact of Postprogression Therapies on Overall Survival.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Baboon hematopoietic cells show limited response to a gene therapy selection system previously effective in mice, dogs, and humans. This variability impacts the development of new gene therapies using large animal models.

Area of Science:

  • Hematology
  • Gene Therapy
  • Translational Medicine

Background:

  • Animal models are crucial for advancing human therapeutics.
  • Gene therapy approaches often show model-specific efficacy.
  • Large animal models are underutilized for comparative gene therapy studies.

Purpose of the Study:

  • To evaluate a novel gene therapy selection system in baboons.
  • To compare baboon hematopoietic cell response to other species.
  • To assess the utility of baboons as a large animal model for gene therapy.

Main Methods:

  • Utilized a conditional thrombopoietin receptor derivative (F36Vmpl) activated by a chemical inducer of dimerization (CID).
  • Assessed proliferation of cultured baboon hematopoietic cells in response to F36Vmpl.

Related Experiment Videos

  • Administered CID in vivo to baboons and monitored hematopoietic cell frequency.

    • Main Results:

    • Baboon hematopoietic cells exhibited a minor and variable response to the F36Vmpl signal in vitro.
    • In vivo CID administration resulted in modest and inconsistent increases in transduced cells in baboons.
    • Observed significant differences compared to robust responses in mice and dogs.

    Conclusions:

    • The F36Vmpl/CID system shows limited efficacy in baboon hematopoietic cells.
    • Baboons may not be a suitable model for this specific gene therapy approach.
    • Findings highlight the need for careful selection of large animal models in gene therapy development.